Navigation Links
New lymphoma therapy may be more effective with fewer side effects
Date:11/3/2010

NEW YORK (Nov. 3, 2010) -- Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.

Researchers at Weill Cornell Medical College have found a combination therapy that is more effective than traditional treatments and is able to kill the cancer cells without harm to surrounding tissues. In a paper published in the Journal of Clinical Investigation on Nov. 1, they report that by targeting a key lymphoma-causing factor called BCL6 with a specific inhibitor called RI-BPI in combination with either a histone deacetylases (HDAC) inhibitor or with a heat shock protein (Hsp90) inhibitor, they were able to suppress and in some cases eradicate human DLBCL in mice. The researchers said their findings provide the basis for rational, targeted combinational therapy for patients with DLBCL.

Dr. Ari Melnick, associate professor of medicine and director of the Raymond and Beverly Sackler Center for Biomedical and Physical Sciences at Weill Cornell Medical College, and his colleagues have been studying ways to kill lymphoma cancer cells more effectively and efficiently than standard treatments.

"Lymphomas are not easy to treat. The standard treatment using monoclonal antibodies and chemotherapy does not work for all patients and can cause undesirable side effects," says Dr. Melnick.

B cells are a type of white blood cell that produces antibodies to fight infections. BCL6 is a master regulatory factor that plays a critical role in keeping lymphoma cells alive. Dr. Melnick's study showed that therapeutic targeting of BCL6 with RI-BPI turned on another factor called EP300, a molecular switch that itself can turn on proteins that can restrain lymphoma cell growth and turn off othe
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New class of drug kills lymphoma cells
2. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
3. Scott & White Healthcare clinical trials target lymphoma, leukemia
4. Lifestyle factors significantly impact survival of non-Hodgkins lymphoma patients, study finds
5. Lifestyle Affects Survival in Non-Hodgkins Lymphoma
6. Study identifies promising treatment for aggressive lymphoma
7. Study shows Hodgkin lymphoma survivors lack post-treatment screening for other cancers
8. Lymphoma Survivors Often Miss Out on Follow-Up
9. Lymphoma patients with cardiovascular disease have increased risk of cardiac hospitalization
10. Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
11. Scott & White Healthcare study aimed at T-cell lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... The American Gastroenterological Association (AGA) Research Foundation is ... The AGA Research Scholar Awards program, launched in ... productive research careers in digestive diseases. This year, ... year allowing for three consecutive years of funding. ... who are paving the way for promising research ...
(Date:4/23/2014)... as wealthy as the United States, it may come as ... access to adequate food due to lack of money or ... research at the University of Illinois using data from the ... seniors who are dealing with hunger are also facing negative ... of Americans over age 60 faced the threat of hungerthat ...
(Date:4/23/2014)... about an increase in adolescents, marijuana use following the ... relief. According to a new study at Rhode Island ... states with and without medical marijuana laws, legalizing the ... The study is published online in advance of print ... , "Any time a state considers legalizing medical marijuana, ...
(Date:4/23/2014)... Methylphenidate, also known as Ritalin, may prevent the depletion ... Science , a journal of the Association for Psychological ... a diet or trying to focus attention on a ... suggests one potential explanation for this difficulty: Exerting self-control ... to exert self-control effectively on subsequent tasks. , "It ...
(Date:4/22/2014)... popular high school sport in the United States with ... researchers in the Center for Injury Research and Policy ... and describe the occurrence and distribution patterns of basketball-related ... athletic training setting among adolescents and teens. , The ... Training , examined data relating to adolescents 13-19 years ...
Breaking Medicine News(10 mins):Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:More Americans in their golden years are going hungry 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:ADHD drug may help preserve our self-control resources 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3
... of the first, study finds , , WEDNESDAY, March 5 (HealthDay ... may be more likely to become pregnant again within two ... of Medicine study. , The study followed 269 predominately black ... care at five community sites. One or two years after ...
... Va. In many cases, when abusive parents with ... physical cruelty, authorities often remove the abused child from ... brothers and sisters of abused children can suffer lifelong ... in extreme cases, from being forced to participate in ...
... Relax The Back corporation,sold a record number of new ... locations were sold last year, and 12 new,stores opened. ... similarly,strong franchise sales results, with four stores already opened ... scheduled to open by June. The,company,s long-term goal is ...
... Members Confront Lazard Execs, Protest,Outside Atria Senior Living ... Workers, family members of,elderly residents at Atria Senior ... owner Lazard,s executives outside their,annual meeting of buyout ... hundreds of facilities across the country., Atria ...
... ability to control impulsive responses, study finds , , WEDNESDAY, ... a substance abuse disorder have deficits in frontal brain activation, ... MRI to study brain activity in 25 participants, ages 12 ... scientists found a link between increased risk for a substance ...
... 5 Secretary of,Health Dr. Calvin B. Johnson met ... in Ellwood City to discuss Governor Edward G. Rendell,s,plan ... thousands of,uninsured adults through his "Cover All Pennsylvanians" proposal., ... prevent disease,successfully manage chronic diseases, such as diabetes and ...
Cached Medicine News:Health News:Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 2Health News:Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 2Health News:Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailer's Prospects for 2008 2Health News:New! Pull Back the Corporate Curtain at www.LazardUnveiled.org 2Health News:Deficit in Brain Function Puts Teens at Risk of Drug Abuse 2Health News:Health Secretary Visits Lawrence County to Call for Health Insurance for All Pennsylvanians 2
(Date:1/15/2014)... 2014 The Cadence Fitness & Health Center has ... Medical Fitness Association, a non-profit organization assisting medically integrated ... The Cadence Fitness & Health Center is the only ... in the Chicagoland area. "The certification means ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... ConvaTec, a world-leading developer and marketer of ... today announced that Holy Family Medical Center will ... line of products designed to overcome the clinical ... Negative Pressure features the Engenex ® System ...
... 2011 iCyt Mission Technology, Inc. (iCyt), a wholly-owned ... introduction of its new line of 405nm-excited fluorochrome conjugated ... products are part of the first commercial release of ... exciting new class of fluorescent probes will make significant ...
Cached Medicine Technology:Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care 2Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care 3iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology 2
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: